Remdesivir no virus silver bullet, says UN health agency

 Remdesivir no virus silver bullet, says UN health agency

An advisory body of the UN health agency is not recommending the use of the high-profile antiviral drug Remdesivir for hospitalized COVID-19 patients, saying on Thursday there is insufficient evidence that it improves survival outcomes or cuts down on the need for patients to be put onto ventilators. Read more